|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Time deposits under trade structured finance program (Note 3) | |||||||||||
| Trade accounts receivable (net of allowances of $161 and $156) (Note 4) | |||||||||||
| Inventories (Note 5) | |||||||||||
| Assets held for sale (Note 2) | |||||||||||
| Other current assets (Note 6) | |||||||||||
| Total current assets | |||||||||||
| Property, plant and equipment, net | |||||||||||
| Operating lease assets | |||||||||||
| Goodwill | |||||||||||
| Other intangible assets, net | |||||||||||
| Investments in affiliates | |||||||||||
| Deferred income taxes | |||||||||||
| Other non-current assets (Note 7) | |||||||||||
| Total assets | |||||||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Short-term debt (Note 13) | |||||||||||
| Current portion of long-term debt (Note 13) | |||||||||||
| Letter of credit obligations under trade structured finance program (Note 3) | |||||||||||
| Trade accounts payable (includes $874 and $559 carried at fair value) (Note 11) | |||||||||||
| Current operating lease obligations | |||||||||||
| Liabilities held for sale (Note 2) | |||||||||||
| Other current liabilities (Note 10) | |||||||||||
| Total current liabilities | |||||||||||
| Long-term debt (Note 13) | |||||||||||
| Deferred income taxes | |||||||||||
| Non-current operating lease obligations | |||||||||||
| Other non-current liabilities (Note 16) | |||||||||||
| Redeemable noncontrolling interest | |||||||||||
| Equity (Note 17): | |||||||||||
| Registered shares, par value $0.01; authorized not issued – 33,632,445 shares; conditionally authorized 32,285,894 shares; issued and outstanding: 2026 – 192,106,786 shares, 2025 – 193,408,656 shares | |||||||||||
| Common shares, par value $0.01; authorized—400,000,000 shares; issued and outstanding: 149,907,932 shares at December 31, 2022 | |||||||||||
| Additional paid-in capital | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive income (loss) (Note 17) | |||||||||||
| Treasury shares, at cost; 2026 - 16,404,977 shares and 2025 - 15,103,107 shares | |||||||||||
| Total Bunge shareholders’ equity | |||||||||||
| Noncontrolling interests | |||||||||||
| Total equity | |||||||||||
| Total liabilities, redeemable noncontrolling interest and equity |
Loading...
